*Attia calls peptides "legitimate but narrow" — a rare honest take from a clinician.*
As of SAT, MAY 9, 10:04 PM · New Brief Daily
Last updated May 9, 2026 — today's curated peptide research brief, refreshed daily.
*Attia calls peptides "legitimate but narrow" — a rare honest take from a clinician.*
Research VialsResearch review of GLP-2 — the incretin hormone studied for intestinal epithelial growth, nutrient absorption, and gut barrier function.
PubMed · Clinical obesityWolsing SK et al., Clinical obesity · 2026 Apr. PMID 41871584.
Fight Aging!New evidence shows aged muscle stem cells are not worn out — they are suppressed by the tissue around them. Remove them from that environment and they recover. This has direct implications for peptide and growth-factor strategies aimed at restoring muscle mass in older adults.
Fight Aging!Researchers tested several IGF-1 (insulin-like growth factor 1) receptor blockers for their ability to slow aging in mice. The IGF-1 axis is one of the most studied longevity pathways, and findings here shape how we think about peptide interventions that target the same signaling network.
Lifespan.ioThe widely discussed dasatinib-plus-quercetin (D+Q) senolytic stack — used to clear aging cells from tissue — caused damage in specific brain regions in mice. The finding doesn't kill the concept, but it adds a real cautionary data point for anyone tracking senolytic research.
Lifespan.ioA new study found creatine stacked on top of power training produced gains beyond exercise alone in older adults. Creatine is increasingly being studied alongside peptide protocols for muscle preservation and recovery.
Dr Trevor BachmeyerWhy Retatrutide Feels Weaker After Tirzepatide (And How to Fix It) I explain why many people feel retatrutide “doesn’t work” after switching from tirzepatide, explaining the issue is biology, not the molecule. I contrast tirzepatide’s GLP-
Cortex LabsEach week we put clips together of highlights of the last week's livestream! In this one we dive deep into a number of TRT topics we all know and love. Let's get into it!! 💥🚀 Hire me to resolve Libido/EQ/Sensation issues on TRT, HRT, or
Cortex LabsEvery Saturday we go LIVE to break down the real science of dialing in libido and erectile quality on TRT. Most men on testosterone replacement therapy are running protocols that are fundamentally broken — wrong dosing strategies, poor hor
Doctor Michael MuellerWelcome to the ultimate resource for Longevity, Hormone Optimization, and Biohacking, led by a Mayo Clinic Trained Family Physician. I'm here to cut through the noise and provide evidence-based strategies for extending your healthspan and d
Dr Alex TatemShawn Ryan Show Pod link: https://www.youtube.com/watch?v=y4ATx9A9y6w BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and
Thomas DeLauerUse Code THOMAS20 for 20% off Your First Order of SEED: https://www.seed.com/thomasyt This video does contain a paid partnership with a brand that helps to support this channel. It is because of brands like this that we are able to provide
Research VialsWhat peptide purity grades mean, how they're measured, and which grade you need for different research applications. A practical guide for laboratory purchasing.
Tim FerrissElad Gil is CEO of Gil & Co, a multi-stage investment firm, holding company, and operating company working on the world’s most advanced technologies. Elad is a serial entrepreneur, operating executive, and investor or advisor to private com
Dave AspreyI used to weigh 300 pounds. I tried every restrictive diet, became a vegan, and trained 90 minutes a day for 18 months with absolute zero results. Everything changed when I drank a cup of yak butter tea at 18,300 feet in Tibet. Within 30 se
eLifeResearchers used fiber photometry to record kisspeptin (a reproductive signaling peptide) neuron activity across the full estrous cycle in female mice. A sustained firing burst preceded each luteinizing hormone surge. The data clarifies how kisspeptin drives ovulation — with implications for reproductive peptide research.
Lifespan.ioRockefeller University professor Junyue Cao discusses his lab's ultra-high-throughput single-cell work published in Science. His team mapped aging across tissue types at cellular resolution — building the kind of atlas that peptide researchers will use to find high-value intervention targets.
BluePrint (Bryan Johnson)Johnson's team reviewed the clinical evidence on skin aging and built a stack around actives that passed that bar. The piece covers what drives photoaging and which ingredients have real data behind them — relevant context for anyone tracking copper peptide and GHK-Cu skin research.
Fight Aging!A Fight Aging! analysis makes the case that immune dysfunction — not just plaques or tangles — is a central cause of neurodegeneration. The inflammaging angle is directly relevant to thymus-targeted peptides like Thymalin and Thymosin Alpha-1, which aim to restore immune competence.
Lifespan.ioIn mice, a period of obesity left T cells stuck in a pro-inflammatory state — even after normal weight returned. The finding adds pressure on metabolic peptide strategies: GLP-1 class drugs may drive weight loss, but immune memory of obesity may require additional intervention.
Peter AttiaThe first trial combining rapamycin with structured exercise returned underwhelming results. Attia breaks down why a single negative trial doesn't close the book on rapamycin as a longevity tool — and what would make future trials more informative.
Research VialsA reference map covering known synergies and potential conflicts between commonly researched peptides. Useful for anyone designing multi-peptide protocols in a lab context — covers receptor competition, pathway overlap, and timing considerations.
Research VialsA side-by-side research comparison of AOD-9604 (a GH fragment studied for fat metabolism) and semaglutide (a GLP-1 receptor agonist). The two compounds target fat loss through different mechanisms — this piece maps where the evidence is strong and where it thins out.
Research VialsComparing 5-Amino-1MQ (NNMT inhibitor) and SLU-PP-332 (ERR agonist) — two different approaches to metabolic and exercise mimetic research.
Lifespan.ioResearchers mapped how intestinal aging lets harmful bacteria gain ground by degrading the mucosal immune layer. The gut-immune link is increasingly central to longevity research — and intersects with GLP-2 and peptide gut-health research.